EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock of Merrimack Pharmaceuticals, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit thereto. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 25th day of January 2024.

 

  Newtyn Management, LLC
   
  By: /s/ Noah G. Levy
    Noah G. Levy, Managing Member

 

  Newtyn Partners, LP
   
  By: Newtyn Management, LLC
  Its: Investment Manager
     
  By: /s/ Noah G. Levy
    Noah G. Levy, Managing Member

 

  Newtyn TE Partners, LP
   
  By: Newtyn Management, LLC
  Its: Investment Manager
     
  By: /s/ Noah G. Levy
    Noah G. Levy, Managing Member

 

  Newtyn Capital Partners, LP
   
  By: Ledo Capital, LLC
  Its: General Partner
   
  By: /s/ Noah G. Levy
    Noah G. Levy, Managing Member

 

  Ledo Capital, LLC
   
  By: /s/ Noah G. Levy
    Noah G. Levy, Managing Member

 

    /s/ Noah G. Levy
    Noah G. Levy